ARCHIVES

Broder Hopes To Help “Fundable: Centers, Stops Short Of Promising Compliance With All IOM Points

This article is from The Cancer Letter archive.

Vol. 15 No. 18 | May 5, 1989

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities listed.

May 21, 2004

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

Orphan Designation Granted To Advaxis HPV Immunotherapy

May 30, 2014

NCCS Networker Volume 10 Issue 3, Winter 1996

January 13, 1996

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003

NCI-Approved Clinical Trials

June 25, 2004